{"id":"W4407548248","doi":"10.1002/cncr.35746","title":"Maintenance therapy with the <i>FMS</i>‐like tyrosine kinase 3 inhibitor gilteritinib in patients with <i>FMS</i>‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study","year":2025,"lang":"en","type":"article","venue":"Cancer","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma","keywords":"Medicine; Surgery; Placebo; Gastroenterology; Internal medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Discontinuation; Hazard ratio; Clinical endpoint; Randomized controlled trial; Confidence interval; Pathology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001327518,0.0009046933,0.001795526,0.0002461239,0.0002072201,0.0005311724,0.0005152097,0.0006980138,0.001523926],"category_scores_gemma":[0.0004924963,0.0002742412,0.001514728,0.0002257962,0.0005801868,0.0004965499,0.000207944,0.001344106,0.0003356708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007109579,"about_ca_system_score_gemma":0.0007537414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004605021,"about_ca_topic_score_gemma":0.001237996,"domain_scores_codex":[0.9996861,0.0001300744,0.000024417,0.000061434,0.00004070123,0.0000571765],"domain_scores_gemma":[0.9995395,0.00008399772,0.0001595025,0.00003212924,0.00002611022,0.0001587242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7498948,0.02127896,0.0163655,0.001577467,0.003341635,0.0003192788,0.0002906966,0.002311603,0.04263013,0.0001659401,0.002349499,0.1594744],"study_design_scores_gemma":[0.5602163,0.4000571,0.03155063,0.00007148157,0.001486091,0.0003880551,0.00003857444,0.001069672,0.003071927,0.00009914715,0.001917863,0.00003313358],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945266,0.00356583,0.0002531364,0.0002085125,0.00005460735,0.0005008231,0.0002293561,0.00004847545,0.0006126331],"genre_scores_gemma":[0.995864,0.001787266,0.0005183918,0.0003265558,0.0001495326,0.000545756,0.0004589231,0.000008884049,0.0003405966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001795526,"threshold_uncertainty_score":0.007020652,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01164249238749863,"score_gpt":0.2977045688700433,"score_spread":0.2860620764825447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}